These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15601978)

  • 1. The long-term management of obesity with continuing pharmacotherapy.
    Frank A
    Obes Res; 2004 Nov; 12(11):1821-7. PubMed ID: 15601978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of obesity with "combination" pharmacotherapy.
    Rothman RB
    Am J Ther; 2010; 17(6):596-603. PubMed ID: 19352140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical strategies for weight loss in the overweight and obese patient.
    Di Caro S; Hamad GG; Fernstrom MH; Schauer PR; Bonanomi G
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):415-30. PubMed ID: 17108871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss medications--where do they fit in?
    Dixon JB
    Aust Fam Physician; 2006 Aug; 35(8):576-9. PubMed ID: 16894428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sibutramine plus meal replacement therapy for body weight loss and maintenance in obese patients.
    Early JL; Apovian CM; Aronne LJ; Fernstrom MH; Frank A; Greenway FL; Heber D; Kushner RF; Cwik KM; Walch JK; Hewkin AC; Blakesley V
    Obesity (Silver Spring); 2007 Jun; 15(6):1464-72. PubMed ID: 17557984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study.
    Gaciong Z; Placha G
    J Hum Hypertens; 2005 Sep; 19(9):737-43. PubMed ID: 15905888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patients with type III obesity given sibutramine 15 mg/day lose weight in amounts proportional to those in types I and II, but waist circumferences does not decrease proportionally].
    López-Alvarenga JC; Vargas JA; Schneider-Ehrenberg OP; Comuzzie AG; González J; Martínez JL
    Gac Med Mex; 2007; 143(2):109-14. PubMed ID: 17585697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacologic management of obesity.
    Cerda JJ
    J Fla Med Assoc; 1997 Feb; 84(2):89-92. PubMed ID: 9066231
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological therapies for obesity.
    Kaplan LM
    Gastroenterol Clin North Am; 2005 Mar; 34(1):91-104. PubMed ID: 15823441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appetite suppressants as adjuncts in the treatment of obesity.
    Elks ML
    J Fam Pract; 1996 Mar; 42(3):287-92. PubMed ID: 8636681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term pharmacotherapy for obesity.
    Klein S
    Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of antiobesity drugs.
    Galloway SM; Farquhar DL; Munro JF
    Postgrad Med J; 1984; 60 Suppl 3():19-26. PubMed ID: 6393107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of metformin for weight management in patients without type 2 diabetes.
    Desilets AR; Dhakal-Karki S; Dunican KC
    Ann Pharmacother; 2008 Jun; 42(6):817-26. PubMed ID: 18477733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical interventions in adolescent obesity.
    Khan UI; Collier M
    Adolesc Med State Art Rev; 2008 Dec; 19(3):406-20, viii. PubMed ID: 19227383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sibutramin in obesity treatment (multicenter, open, prospective 12-month-long study)].
    Payer J; Hainer V; Ondrejka P; Kajtor Z
    Vnitr Lek; 2004 Nov; 50(11):825-9. PubMed ID: 15648961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sibutramine to assist obese women with weight loss can be successful in dietitian-led clinics: another tool in the dietitian's toolbox.
    Barratt R; Frost G; O'Boyle A; Millward J; Truby H
    J Hum Nutr Diet; 2008 Jun; 21(3):248-55. PubMed ID: 18477180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of obesity].
    Wechsler JG
    Acta Med Austriaca; 1998; 25(4-5):138-41. PubMed ID: 9879389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patients.
    Finer N; Ryan DH; Renz CL; Hewkin AC
    Diabetes Obes Metab; 2006 Mar; 8(2):206-13. PubMed ID: 16448525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication associated with weight gain may influence outcome in a weight management program.
    Malone M; Alger-Mayer SA; Anderson DA
    Ann Pharmacother; 2005; 39(7-8):1204-8. PubMed ID: 15928261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined dietary and pharmacological weight management in obese hypopituitary patients.
    Mersebach H; Klose M; Svendsen OL; Astrup A; Feldt-Rasmussen U
    Obes Res; 2004 Nov; 12(11):1835-43. PubMed ID: 15601980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.